ETF Exchange > IBRN ETF
IBRN - ETF Fact Sheet
iShares Neuroscience and Healthcare ETF - USD
Fund Identification
Ticker
IBRN
ISIN
US46436E3532
Main Metrics
Price
$37.89Expense Ratio
0.47%AuM
$5.68MTracking Difference
-0.74%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The iShares Neuroscience and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
IBRN's historical prices, performance, and flows
1m returns
9.56%
1m flows
$0M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all IBRN data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
IBRN's characteristics
Manager
Manager statistics
1787 funds, $6,329.73Bn in AUM
Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
IBRN's exposure
Countries
USA
69.81%
Other
30.19%
Sectors
Healthcare
99.90%
Top 5 holdings
Alkermes Plc
5.05%
Axsome Therapeutics, Inc.
4.96%
Xenon Pharmaceuticals, Inc.
4.50%
Arrowhead Pharmaceuticals, Inc.
4.47%
Neurocrine Biosciences, Inc.
4.26%
Total holdings
74
Total weight of top 5
23.24%
